Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.55
0.00 (0.00%)
Oct 8, 2026, 2:28 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 549.33 million as of October 9, 2026. It is the 38,216th most valuable company in the world and the 2,250th biggest in Taiwan. Its market cap has decreased by 25.96% in one year.
Market Cap
549.33M
Enterprise Value
383.68M
Revenue
54.81M
Global Rank
Country Rank
#2,250 Taiwan
PE Ratio
4.67
ChartMarket Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 549.33M, an increase of 39.69%. That is a compound annual growth rate of 2.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 549.33M | -10.36% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 974.16M |
| TCI GENE | 961.77M |
| NatureWise Biotech & Medicals | 838.30M |
| Lukas Biomedical | 774.68M |
| MegaPro Biomedical | 773.43M |
| BioLASCO Taiwan | 729.94M |
| Taiwan Advance Bio-Pharmaceutical | 706.50M |
| Neith | 703.95M |